“Mechanical thrombectomy techniques and devices have improved significantly over the years, but limitations remain. These range from difficulties with distal blood flow arrest and clot fragmentation to no or low reperfusion at first pass,” said Dr. Andersson. “In the in vitro model, with the Advanced Thrombectomy System, operators were able to overcome these challenges. Assuming these results can be replicated clinically, I believe this system has tremendous potential for fast, effective yet safe endovascular treatment of patients suffering from a major stroke.”
Medical Device News Magazine keeps our readers up-to-date on breaking medical device industry news and more!